Holen Sie sich die Stockscreener-App
0.7481
3.94%
-0.0307
Handel nachbörslich:
.73
-0.0181
-2.42%
Schlusskurs vom Vortag:
$0.7788
Offen:
$0.7849
24-Stunden-Volumen:
2.24M
Relative Volume:
1.64
Marktkapitalisierung:
$73.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-93.61M
KGV:
-0.3545
EPS:
-2.11
Netto-Cashflow:
$-71.16M
1W Leistung:
-10.41%
1M Leistung:
-23.53%
6M Leistung:
-34.95%
1J Leistung:
-37.13%
1-Tages-Spanne:
$0.7262
$0.7854
1-Wochen-Bereich:
$0.7262
$0.8699
52-Wochen-Spanne:
$0.561
$1.42
Immunic Inc Stock (IMUX) Company Profile
Firmenname
Immunic Inc
Sektor
Branche
Telefon
(332) 255-9818
Adresse
1200 AVENUE OF THE AMERICAS, NEW YORK
Vergleichen Sie IMUX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.7481 | 76.83M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-25 | Eingeleitet | William Blair | Outperform |
| 2024-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-27 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-04-15 | Eingeleitet | Aegis Capital | Buy |
| 2021-03-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-07 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-20 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-06-05 | Eingeleitet | Wedbush | Outperform |
| 2020-05-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-07-11 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Immunic Inc Aktie (IMUX) Neueste Nachrichten
Will Immunic Inc. (10VA) stock outperform global peersSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Forecasting Immunic Inc. price range with options data2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Is Immunic Inc. stock a top momentum playJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
Evaluating Immunic Inc. with trendline analysis2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What does recent volatility data suggest for Immunic Inc.2025 Key Lessons & AI Driven Price Predictions - newser.com
Is Immunic Inc. (10VA) stock a momentum leaderMarket Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com
What high frequency data says about Immunic Inc.July 2025 Levels & Real-Time Stock Entry Alerts - newser.com
News impact scoring models applied to Immunic Inc.Volume Spike & Daily Growth Stock Tips - newser.com
Will Immunic Inc. stock see PE expansionWall Street Watch & Long-Term Investment Growth Plans - newser.com
Is Immunic Inc. (10VA) stock positioned for secular growthTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Immunic to Participate in Industry and Investor Conferences in November - Sahm
Is Immunic Inc. stock resilient to inflation2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Immunic (IMUX) Price Target Decreased by 17.29% to 6.41 - MSN
Price momentum metrics for Immunic Inc. explainedJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Immunic, Inc. (IMUX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What sentiment indicators say about Immunic Inc. stockQuarterly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Immunic (IMUX) to Release Quarterly Earnings on Thursday - MarketBeat
Why Immunic Inc. (10VA) stock benefits from AI revolutionWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Is Immunic Inc. stock supported by strong fundamentalsWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Is Immunic Inc. stock attractive for growth ETFs2025 Top Gainers & Fast Moving Stock Trade Plans - newser.com
EQS-News: Immunic to Participate in Industry and Investor Conferences in November - sharewise.com
EQS-News: Immunic AG: Immunic to Participate in Industry and Investor Conferences in November - FinanzNachrichten.de
Immunic (NASDAQ: IMUX) to join BIO-Europe Vienna and Jefferies London in November - Stock Titan
Immunic to participate in BIO-Europe and Jefferies Global Healthcare conferences in November - Proactive financial news
Will Immunic Inc. stock continue dividend increases2025 EndofYear Setup & Growth Focused Investment Plans - Fundação Cultural do Pará
Finanzdaten der Immunic Inc-Aktie (IMUX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immunic Inc-Aktie (IMUX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
| Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):